Review on Mental health illness in patient with hyper androgenic anovulation

Authors

  • Sathyapriya K Pharm D intern, Department of Pharmacy Practice, J.K.K. Nattraja College of Pharmacy, Kumarapalayam - 638183, Tamil Nadu, India
  • Mebin Alias Assistant Professor & Clinical Preceptor, Department of Pharmacy Practice, J.K.K. Nattraja college of pharmacy, Kumarapalayam, Tamilnadu, India

Keywords:

Anxiety, Depression, Hyperandrogenism, Infertility, Obesity

Abstract

Hyper androgenic anovulation (HA) is also called as polycystic ovary syndrome (PCOS). It concerned with the monthly cycle abnormalities, hyperandrogenism and obesity. The functioning of HA remains unclear, but basic imperfections in the hypothalamus pituitary axis, insulin secretion and action of ovarian function. The clinical symptoms highlighted by the HA patient was obesity, acne, hirsutism, infertility and irregular menstrual cycle. Above 50% of patients develop diabetes, heart attack, dyslipidemia, blood pressure, anxiety, depression, endometrial cancer and sleep apnea after HA was diagnosed. It affects the patient’s quality of life and resulted in emotional disorder and psychological problems. The physical health, mental health and social health of HA patient were totally affected. So the study concluded that the patients with PCOS are more prone to depression and anxiety which affects the quality of life. Weight loss and dietary management have been improved the ovulation and insulin sensitivity in PCOS patient. So early clinical intervention in PCOS patient and psychological supports will improve the patient mental health and quality of life.

Downloads

Published

2020-05-31

How to Cite

Sathyapriya K, & Mebin Alias. (2020). Review on Mental health illness in patient with hyper androgenic anovulation. World Journal of Pharmaceutical Sciences, 8(6), 109–114. Retrieved from https://wjpsonline.com/index.php/wjps/article/view/169

Issue

Section

Review Article

Most read articles by the same author(s)